Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here Is What You Need to Know
Gilead Sciences: A Balanced Hold Rating Amidst Growth Prospects and Market Challenges
Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD) and Premier (PINC)
Wells Fargo Maintains Gilead Sciences(GILD.US) With Hold Rating, Maintains Target Price $78
Gilead Sciences to Present at Upcoming Investor Conferences
The 20 Most Popular Mutual Fund Increases During 2Q - Goldman Sachs
FTC Says FDA Biosimilar Guidance Would Increase Competition, Lead to Lower Prices
How To Earn $100 Per Month From Gilead Sciences Stock
Peering Into Gilead Sciences's Recent Short Interest
Gilead Sciences: "One of Best Employers for Women" by Forbes
Building a Bridge to a Healthier World for Youth in Africa With Gilead Sciences
Mpox Outbreak Has World on High Alert. What to Know
Gilead (GILD) Obtains FDA Approval for PBC Drug Livdelzi
Express News | Pantherx Rare Partnering With Gilead Sciences For Distribution Of Livdelzi
Express News | Pantherx® Rare Partnering With Gilead Sciences, Inc. for Distribution of Livdelzi®
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Express News | Truist Securities Maintains Hold on Gilead Sciences, Raises Price Target to $83
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal